Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Larissa N'guessan-Koffi"'
Autor:
Anani Badje, MPH, Raoul Moh, PhD, Delphine Gabillard, MSc, Calixte Guéhi, PhD, Mathieu Kabran, PharmD, Jean-Baptiste Ntakpé, MPH, Jérôme Le Carrou, PhD, Gérard M Kouame, MPH, Eric Ouattara, PhD, Eugène Messou, PhD, Amani Anzian, MD, Albert Minga, PhD, Joachim Gnokoro, MD, Patrice Gouesse, MD, Arlette Emieme, PharmD, Thomas-d'Aquin Toni, PhD, Cyprien Rabe, MD, Baba Sidibé, MD, Gustave Nzunetu, MD, Lambert Dohoun, MD, Abo Yao, MPH, Synali Kamagate, MD, Solange Amon, MD, Amadou-Barenson Kouame, MD, Aboli Koua, MD, Emmanuel Kouamé, MD, Marcelle Daligou, MD, Denise Hawerlander, MD, Simplice Ackoundzé, MD, Serge Koule, MD, Jonas Séri, MD, Alex Ani, MD, Fassery Dembélé, MD, Fatoumata Koné, MD, Mykayila Oyebi, MD, Nathalie Mbakop, MD, Oyewole Makaila, MD, Carolle Babatunde, MD, Nathaniel Babatunde, MD, Gisèle Bleoué, MD, Mireille Tchoutedjem, MD, Alain-Claude Kouadio, MD, Ghislaine Sena, MD, Sahinou-Yediga Yededji, MD, Sophie Karcher, MSc, Prof Christine Rouzioux, PhD, Abo Kouame, MD, Rodrigue Assi, MD, Alima Bakayoko, MD, Prof Serge K Domoua, PhD, Nina Deschamps, MPH, Prof Kakou Aka, MD, Prof Thérèse N'Dri-Yoman, MD, Prof Roger Salamon, PhD, Valérie Journot, PhD, Prof Hughes Ahibo, PhD, Prof Timothée Ouassa, PhD, Prof Hervé Menan, PhD, Prof André Inwoley, PhD, Christine Danel, PhD, Prof Serge P Eholié, PhD, Dr Xavier Anglaret, PhD, Anani Badje, Raoul Moh, Delphine Gabillard, Calixte Guéhi, Mathieu Kabran, Jean-Baptiste Ntakpé, Jérôme Le Carrou, Gérard-Menan Kouame, Eric Ouattara, Eugène Messou, Amani Anzian, Albert Minga, Joachim Gnokoro, Patrice Gouesse, Arlette Emieme, Thomas-d'Aquin Toni, Cyprien Rabe, Baba Sidibé, Gustave Nzunetu, Lambert Dohoun, Yao Abo, Synali Kamagate, Solange Amon, Amadou-Barenson Kouame, Aboli Koua, Emmanuel Kouamé, Marcelle Daligou, Denise Hawerlander, Simplice Ackoundzé, Serge Koule, Jonas Séri, Alex Ani, Fassery Dembélé, Fatoumata Koné, Mykayila Oyebi, Nathalie Mbakop, Oyewole Makaila, Carolle Babatunde, Nathaniel Babatunde, Gisèle Bleoué, Mireille Tchoutedjem, Alain-Claude Kouadio, Ghislaine Sena, Sahinou-Yediga Yededji, Sophie Karcher, Christine Rouzioux, Abo Kouame, Rodrigue Assi, Alima Bakayoko, Serge-K. Domoua, Nina Deschamps, Kakou Aka, Thérèse N'Dri-Yoman, Roger Salamon, Valérie Journot, Hughes Ahibo, Timothée Ouassa, Hervé Ménan, André Inwoley, Ben-Ahoussi Ndja, Blandine Adou, Constance Kanga, Eba Aoussi, Emmanuel Bissagnene, Olivier Ba-Gomis, Yves-Alain Zike, Claude Akakpo, Madeleine Sassan-Morokro, Max Mobio, Bamba Doféré, Koman Mesmin, Alain Attia, Alassane Mahassadi, Apollinaire Horo, Armel Oussou, Marie-Laure Chaix, Gilles Peytavin, Mariatou Koné, Kouamé N'Guessan, Raïmi Fassassi, Serge Niangoran, Annabel Desgrées-du-Loû, France Lert, Rosemary Dray Spira, Kevin Jean, Romuald Konan, Franck Bohoussou, Cyril Yao-Yapi, Larissa N'guessan-Koffi, Bertine Siloué, Adoulaye Cissé, Adrienne Aboua, Sylvie Konan, Antoine Kouamé, Celestin N'Chot, Elvis Amani, Gwenaëlle Clouet, Bruno Debono, Geneviève Chêne, Mireille Dosso, Pierre-Marie Girard, Vincent Jarlier, Jean-Marie Masumbuko, Christian Perronne, Papa-Salif Sow, Christine Danel, Serge-Paul Eholié, Xavier Anglaret
Publikováno v:
The Lancet Global Health, Vol 5, Iss 11, Pp e1080-e1089 (2017)
Background: Temprano ANRS 12136 was a factorial 2 × 2 trial that assessed the benefits of early antiretroviral therapy (ART; ie, in patients who had not reached the CD4 cell count threshold used to recommend starting ART, as per the WHO guidelines t
Externí odkaz:
https://doaj.org/article/c5d7eb49263d4e08a3d2d62ed936400d
Autor:
Claire Levy-Marchal, Jackson Katembo Vihundira, Sampson Omagbemi Owhin, Marion Bérerd-Camara, Justine Schaeffer, Sophie Duraffour, Johnson Etafo, Alex P. Salam, Chukwuyem Abejegah, Adewale Oladayo Akinpelu, Alexandre Duvignaud, Delphine Gabillard, Camille le Gal, Josephine Funmilola Alabi, Peter Horby, Kader Issaley, Abiodun Tolani Abidoye, Eric Ouattara, Moronke Uzuajemeh Ireneh, Denis Malvy, Liasu Adeagbo Ahmed, Ijeoma Chukwudumebi Etafo, Mahamadou Doutchi, Olufunke Gbenga-Ayeni, Benjamin Séri, Irmine Ahyi, Moses Adeniyi Adedokun, Ephraim Ogbaini-Emovon, Kehinde Gbemisola Fadiminiyi, Oyebimpe Ope Oyegunle, Akinola Nelson Adedosu, Ayoleyi Omowunmi Dede, Jean-Paul de Bruyne Mushenvula, Patience Iziegbe Ehigbor, Elvis Amani, Nicolas Danet, Titilola Deborah Sule, Marie Jaspard, Mamoudou Diabaté, B. Serra, Bertine Siloué, Stephan Günther, Augustin Augier, Larissa N'guessan-Koffi, Sophie Karcher, Oladele Oluwafemi Ayodeji, Xavier Anglaret, Macdonald Nonso Onyechi
Publikováno v:
The Lancet global health
The Lancet global health, Elsevier, 2021, 9 (4), pp.e469-e478. ⟨10.1016/s2214-109x(20)30518-0⟩
The Lancet. Global Health
The Lancet global health, Elsevier, 2021, 9 (4), pp.e469-e478. ⟨10.1016/s2214-109x(20)30518-0⟩
The Lancet. Global Health
Summary Background Lassa fever is a viral haemorrhagic fever endemic in parts of west Africa. New treatments are needed to decrease mortality, but pretrial reference data on the disease characteristics are scarce. We aimed to document baseline charac
Autor:
Peter Horby, Marie Jaspard, Liasu Adeagbo Ahmed, Mahamadou Doutchi, Ephraim Ogbaini-Emovon, Bertine Siloué, Irmine Ahyi, Claire Levy-Marchal, Justine Schaeffer, Josephine Funmilola Alabi, Ijeoma Chukwudumebi Etafo, Alex P. Salam, Denis Malvy, Stephan Günther, Olufunke Gbenga-Ayeni, Adewale Oladayo Akinpelu, Larissa N'guessan-Koffi, Eric Ouattara, Delphine Gabillard, Johnson Etafo, Oyebimpe Ope Oyegunle, Chukwuyem Abejegah, Alexandre Duvignaud, Augustin Augier, Moronke Uzuajemeh Ireneh, Mamoudou Diabaté, Moses Adeniyi Adedokun, Kehinde Gbemisola Fadiminiyi, Sophie Karcher, B. Serra, Akinola Nelson Adedosu, Ayoleyi Omowunmi Dede, Patience Iziegbe Ehigbor, Oladele Oluwafemi Ayodeji, Macdonald Nonso Onyechi, Xavier Anglaret, Elvis Amani
Publikováno v:
Travel Medicine and Infectious Disease
Travel Medicine and Infectious Disease, Elsevier, 2020, 36, pp.101557-. ⟨10.1016/j.tmaid.2020.101557⟩
Travel Medicine and Infectious Disease, Elsevier, 2020, 36, pp.101557-. ⟨10.1016/j.tmaid.2020.101557⟩
Background Lassa Fever (LF), is a severe viral disease prevalent in Western Africa. It is classified as a priority disease by the World Health Organization (WHO). Ribavirin is the recommended therapy despite weak evidence of its efficacy. Promising t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511fe948572146ea2cce8872d3d076fd
https://hal.archives-ouvertes.fr/hal-03492166
https://hal.archives-ouvertes.fr/hal-03492166